Cargando…

Can Immune Tolerance Be Re-established in Neuromyelitis Optica?

Neuromyelitis optica (NMO) is a chronic inflammatory disease of the central nervous system that primarily affects the optic nerves and spinal cord of patients, and in some instances their brainstem, diencephalon or cerebrum as spectrum disorders (NMOSD). Clinical and basic science knowledge of NMO h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loda, Eileah, Arellano, Gabriel, Perez-Giraldo, Gina, Miller, Stephen D., Balabanov, Roumen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721118/ https://www.ncbi.nlm.nih.gov/pubmed/34987468 http://dx.doi.org/10.3389/fneur.2021.783304

Ejemplares similares

Case report: Use of granulocyte-colony stimulating factor as an immunomodulatory therapy in a patient with neuromyelitis optica spectrum disorder and comorbid immunodeficiency
por: Perez Giraldo, Gina S., et al.
Publicado: (2023)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023)

Editorial: Advances in neuromyelitis optica spectrum disorders
por: Cai, Yu, et al.
Publicado: (2022)

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder
por: Thöne, Jan, et al.
Publicado: (2018)

Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum Disorders
por: Tian, De-Cai, et al.
Publicado: (2020)

Eculizumab Pharmacokinetics and Pharmacodynamics in Patients With Neuromyelitis Optica Spectrum Disorder
por: Singh, Pratap, et al.
Publicado: (2021)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
por: Hor, Jyh Yung, et al.
Publicado: (2020)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Arslan, Burak, et al.
Publicado: (2021)

Case Report: Interferon-Alpha-Induced Neuromyelitis Optica Spectrum Disorder
por: Rao, Jie, et al.
Publicado: (2022)

Efficacy of Low-Dose Rituximab on Neuromyelitis Optica-Associated Optic Neuritis
por: Zhao, Shuo, et al.
Publicado: (2021)

Eculizumab for acute relapse of neuromyelitis optica spectrum disorder: Case report
por: Chatterton, Sophie, et al.
Publicado: (2022)

Intractable nausea and vomiting as presenting manifestation of neuromyelitis optica
por: Jagtap, Sujit A., et al.
Publicado: (2013)

White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder
por: Cho, Eun Bin, et al.
Publicado: (2018)

Neuromyelitis Optica Spectrum Disorder: A Rare Case of Isolated Brainstem Syndrome
por: Bui, Mai-Lynn, et al.
Publicado: (2019)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
por: Baert, Laurie, et al.
Publicado: (2021)

Identifying different cognitive phenotypes and their relationship with disability in neuromyelitis optica spectrum disorder
por: Kong, Lingyao, et al.
Publicado: (2022)

Double seropositive neuromyelitis optica associated with COVID-19: A case report
por: Antonescu Ghelmez, Dana, et al.
Publicado: (2022)

Understanding the employment impact of neuromyelitis optica spectrum disorder in the USA: Mixed methods
por: Mateen, Farrah J., et al.
Publicado: (2023)

Restoring immune tolerance in neuromyelitis optica: Part I
por: Steinman, Larry, et al.
Publicado: (2016)

Restoring immune tolerance in neuromyelitis optica: Part II
por: Bar-Or, Amit, et al.
Publicado: (2016)

Diagonistic Apraxia: A Unique Case of Corpus Callosal Disconnection Syndrome and Neuromyelitis Optica Spectrum Disorder
por: Shozawa, Hidenobu, et al.
Publicado: (2018)

Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features
por: Oertel, Frederike Cosima, et al.
Publicado: (2019)

The Impact of COVID-19 on Patients With Neuromyelitis Optica Spectrum Disorder Beyond Infection Risk
por: Yin, Hexiang, et al.
Publicado: (2021)

Superficial Macula Capillary Complexity Changes Are Associated With Disability in Neuromyelitis Optica Spectrum Disorders
por: Wei, Ruili, et al.
Publicado: (2021)

An Experimental Model of Neuromyelitis Optica Spectrum Disorder–Optic Neuritis: Insights Into Disease Mechanisms
por: Soerensen, Sofie Forsberg, et al.
Publicado: (2021)

Optical Coherence Tomography Angiography (OCTA) in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
por: Kleerekooper, Iris, et al.
Publicado: (2020)

Neuromyelitis Optica Spectrum Disorder: A Rare Case of Transverse Myelitis and Autonomic Dysfunction
por: Bugshan, Turki F, et al.
Publicado: (2023)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Visualizing the Central Nervous System: Imaging Tools for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
por: Kuchling, Joseph, et al.
Publicado: (2020)

Pregnancy and Neuromyelitis Optica Spectrum Disorder – Reciprocal Effects and Practical Recommendations: A Systematic Review
por: D'Souza, Rohan, et al.
Publicado: (2020)

Triglyceride Level Is an Independent Risk Factor in First-Attacked Neuromyelitis Optica Spectrum Disorders Patients
por: Wu, Kaimin, et al.
Publicado: (2019)

Mirror-Image Lesions in Sequential Relapses of AQP4-Positive Neuromyelitis Optica Spectrum Disorder
por: Muir, Ryan T., et al.
Publicado: (2020)

Deep Learning-Based Method to Differentiate Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis
por: Kim, Hyunjin, et al.
Publicado: (2020)

Association of Circulating T Follicular Helper Cells With Idiopathic Optic Neuritis and Neuromyelitis Optica Spectrum Disorders
por: Wu, Qian, et al.
Publicado: (2021)

COVID-19 Vaccination Attitudes With Neuromyelitis Optica Spectrum Disorders: Vaccine Hesitancy and Coping Style
por: Xu, Yafang, et al.
Publicado: (2021)

Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders
por: Kim, Hyunjin, et al.
Publicado: (2022)

Eculizumab in the Treatment of Aquaporin-4 Seronegative Neuromyelitis Optica Spectrum Disorder: A Case Report
por: Digala, Lakshmi, et al.
Publicado: (2021)

Neuromyelitis optica spectrum disorder in Western China impacts employment and increases financial burden in women
por: Han, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5v7f64q6dpjbm2upd018bf324j